Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16767510rdf:typepubmed:Citationlld:pubmed
pubmed-article:16767510lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16767510lifeskim:mentionsumls-concept:C0003805lld:lifeskim
pubmed-article:16767510lifeskim:mentionsumls-concept:C0815000lld:lifeskim
pubmed-article:16767510lifeskim:mentionsumls-concept:C0015744lld:lifeskim
pubmed-article:16767510lifeskim:mentionsumls-concept:C2911691lld:lifeskim
pubmed-article:16767510lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:16767510lifeskim:mentionsumls-concept:C2348609lld:lifeskim
pubmed-article:16767510lifeskim:mentionsumls-concept:C0758515lld:lifeskim
pubmed-article:16767510pubmed:issue3lld:pubmed
pubmed-article:16767510pubmed:dateCreated2006-6-12lld:pubmed
pubmed-article:16767510pubmed:abstractText1. The analogies between the processing of amyloid precursor protein (APP) and other transmembrane sterol regulatory element binding proteins (SREBPs) inspired us to conduct further studies on whether beta-amyloid (Abeta) affects aromatase by interacting with APP and SREBP. 2. In this study, cultured human neuroblastoma cells (SHSY-5Y) were incubated in experimental media (media without FBS, the main cholesterol source) in the presence or absence of Abeta (1 microM) for 24 h. 3. Cellular extracts were subjected to immunoblot analysis using anti-APP, anti-aromatase and anti-SREBP-1. In these cell lines, we detected aromatase (55 kDa), SREBP cleavage product (68 kDa) and APP precursor (100-95 kDa) and cleavage product (60 kDa) by immunoblotting. Aromatase and SREBP levels were elevated in the cells incubated 24 h in experimental media and were attenuated in Abeta-supplemented experimental media. 4. The disturbance of cholesterol homeostasis appears to be an important factor in the pathogenesis of Alzheimer's disease. These findings may have important implications for understanding the mechanisms of the aromatase enzyme gene in disease states such as Alzheimer's.lld:pubmed
pubmed-article:16767510pubmed:languageenglld:pubmed
pubmed-article:16767510pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:citationSubsetIMlld:pubmed
pubmed-article:16767510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16767510pubmed:statusMEDLINElld:pubmed
pubmed-article:16767510pubmed:monthMaylld:pubmed
pubmed-article:16767510pubmed:issn0272-4340lld:pubmed
pubmed-article:16767510pubmed:authorpubmed-author:KelicenPelinPlld:pubmed
pubmed-article:16767510pubmed:authorpubmed-author:NordbergAgnet...lld:pubmed
pubmed-article:16767510pubmed:issnTypePrintlld:pubmed
pubmed-article:16767510pubmed:volume26lld:pubmed
pubmed-article:16767510pubmed:ownerNLMlld:pubmed
pubmed-article:16767510pubmed:authorsCompleteYlld:pubmed
pubmed-article:16767510pubmed:pagination225-35lld:pubmed
pubmed-article:16767510pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:meshHeadingpubmed-meshheading:16767510...lld:pubmed
pubmed-article:16767510pubmed:year2006lld:pubmed
pubmed-article:16767510pubmed:articleTitleFeedback regulation of SREBP and aromatase in A beta(25-35)-supplemented human neuroblastoma cells.lld:pubmed
pubmed-article:16767510pubmed:affiliationFaculty of Pharmacy, Department of Pharmacology, Hacettepe University, 06100 Sihhiye, Ankara, Turkey. pkelicen@hacettepe.edu.trlld:pubmed
pubmed-article:16767510pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16767510pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1588entrezgene:pubmedpubmed-article:16767510lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16767510lld:entrezgene